MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, ...

The study, published today in JAMA Network Open, tracked patients hospitalized for hip fractures in Victoria, Australia from March 2013 through June 2018, who had used gabapentinoids before the injury ...

A new joint study by the University of Eastern Finland and Karolinska Institutet in Sweden found that the GLP-1 agonists semaglutide and liraglutide, which are used for treating diabetes and obesity, ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

Researchers discovered that a healthy low-carb diet and time-restricted eating, combined with moderate calorie restriction, ...

The FDA Modernization Act of 1997 established the Fast Track designation to expedite developing and reviewing new drugs ...

This article summarizes a discussion at LSX Biopharm America on September 11. A panel of industry experts discussed ...

The pharmaceutical industry’s approach to data integrity has been historically manual, leveraging physical documentation and ...

Ijeoma Uchegbu discusses nanomedicine's role in improving medication adherence and developing non-addictive pain relief ...

Professor Nancy Ip discusses her groundbreaking neuroscience research, focusing on neurotrophic factors and innovative ...

Research on HEPA-14 air purifiers in aged care reveals no significant impact on respiratory infections, though initial phase ...

POINT is an innovative EU-funded project focused on advancing healthcare for individuals affected by Covid-19.